PPARγ is dispensable for clear cell renal cell carcinoma progression

OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) is a subtype of kidney cancer defined by robust lipid accumulation, which prior studies have indicated plays an important role in tumor progression. We hypothesized that the peroxisome proliferator-activated receptor gamma (PPARγ), detected in both...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Metab
Autores principales: Sanchez, Danielle J., Steger, David J., Skuli, Nicolas, Bansal, Ankita, Simon, M. Celeste
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034040/
https://ncbi.nlm.nih.gov/pubmed/29866440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2018.05.013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares